PAR 0.00% 29.0¢ paradigm biopharmaceuticals limited..

Ann: Successful MPSVI Safety Review and PARA OA 008 Update, page-36

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    @hamman

    I don't think PAR would even know where to start when analysing this kind of data. It's a lot more complicated than calculating averages, standard deviations and confidence intervals.

    The raw data are signals i.e. relative intensities, which require normalisation and / or comparison to a standard. Depending on the method specified in the SAP, which outlines the method the CRO will use, it could involve cluster analysis followed by some type of significance test. They will also need to calculate all other relevant stats e.g. power etc, prior to presenting the results back to PAR in a form they can understand.

    So I doubt PAR know the results yet.


    Last edited by Zenox: 26/09/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
0.000(0.00%)
Mkt cap ! $101.4M
Open High Low Value Volume
28.5¢ 29.5¢ 28.5¢ $79.93K 274.7K

Buyers (Bids)

No. Vol. Price($)
2 12951 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 23984 3
View Market Depth
Last trade - 16.10pm 08/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.